Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2025

Feb 3, 2025

60507_rns_2025-02-03_deb12e03-0bf3-4b24-ab99-5ec75972db75.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

February 3, 2025

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”).

Pursuant to the Regulation 30 of the Listing Regulations, we wish to inform that, the Office of the Assistant Commissioner, Central GST Division, Panchkula, Panchkula Ward 3, Ambala, Haryana through its Order dated February 1, 2025 (“Order”), has levied a Tax demand of Rs. 43,95,190/- and a Penalty of Rs. 43,95,190/ aggregating to a total demand of Rs. 87,90,380/-.

Based on our assessment, we believe that the said demand is not maintainable and the Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.

Please note that, the Company received the said Order on a non-working day, i.e., February 1, 2025, and the intimation under Regulation 30 is submitted on the immediate next working day, i.e., February 3, 2025.

Additional details required to be disclosed pursuant to the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

Digitally signed by PRAJEET PRAJEET NAIR NAIR Date: 2025.02.03 20:55:14 +05'30'

Prajeet Nair

Director – Corporate Services & Company Secretary

Encl.: A/a

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Annexure A

Additional information pursuant to SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sr.No.1.2.3.4.5. ParticularsName of AuthorityNature and details of the action(s) taken,initiated or order(s) passedDate of receipt of direction or order, includingany ad-interim or interim orders, or any othercommunication from the authority.Details of the violation(s) / contravention(s)committed or alleged to be committed.Impact on financial, operation or otheractivities of the listed entity, quantifiable inmonetary terms to the extent possible DetailsAssistant Commissioner, Central GSTDivision,Panchkula,PanchkulaWard 3,Ambala,HaryanaOrder Ref No. ZD0602250005900dated February 1, 2025, passedunderSection73(9)/74(9)/127/129(3)/130 of Central Goods andServices Tax Act, 2017 /HaryanaGoods and Services Tax Act, 2017 forlevyofTaxdemandofRs. 43,95,190/- and a Penalty ofRs. 43,95,190/ aggregating to a totaldemand of Rs. 87,90,380.February 1, 2025.The Officer has raised the demandand the penalty on the ground_, inter_alia, that the original documentswere not received for verification bytheAuthority.However,theCompany had provided photocopiesof the duty paying documents to theCentral Tax Officer for verification.There is no material impact onfinancials,operationsorotheractivities of the Company.The Company believes that the saiddemand is not maintainable and theCompany is in the process ofpreferring to file an appeal againstthe said order/demand.